Simona King - Mar 15, 2023 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Chief Financial Officer
Signature
/s/ Edgar Cale, Attorney-in-Fact
Stock symbol
PASG
Transactions as of
Mar 15, 2023
Transactions value $
$0
Form type
4
Date filed
4/5/2023, 07:29 PM
Previous filing
Nov 14, 2022
Next filing
Apr 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Employee Stock Option (right to buy) Award $0 +140K $0.00 140K Mar 15, 2023 Common Stock 140K $1.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as of 1/48 of the total shares monthly beginning on April 15, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.